Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/13/1991 | WO1991007998A1 IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH |
06/13/1991 | WO1991007982A1 Treatment of hsv |
06/13/1991 | WO1991007974A1 Topical therapeutic preparation |
06/13/1991 | WO1991007970A1 Medicine containing thiazine dioxide derivative |
06/13/1991 | WO1991007969A1 Use of caffeine in the treatment of herpes simplex virus infections |
06/13/1991 | WO1991007968A1 Hydrochloride 2,3,3a,4,5,6-hexahydro-8-cyclohexyl-1h-pyrazino (3,2,1-j,k)carbazol, method of obtaining it and a pharmaceutical preparation of antidepressive action based on it |
06/13/1991 | WO1991007967A2 Method of preventing or limiting reperfusion damage |
06/13/1991 | WO1991007964A1 Fat emulsion |
06/13/1991 | WO1991007962A1 Fat emulsion |
06/13/1991 | WO1991007960A1 Pharmaceutical compositions for the treatment of ataxy and equilibrium problems |
06/13/1991 | WO1991007958A1 Pharmaceutical preparation-protector of myocardium under ischemia and reperfusion |
06/13/1991 | WO1991007957A1 Method of treatment of human immunodeficiency virus |
06/13/1991 | WO1991007956A1 Use of anipamil for treating chronic renal insufficiency |
06/13/1991 | WO1991007955A1 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders |
06/13/1991 | WO1991007954A1 Use of guanidinoacetic acid to induce an increase of the creatine contents in muscles |
06/13/1991 | WO1991007953A1 Tumour necrosis factor antagonist |
06/13/1991 | WO1991007950A1 Pharmaceutical compositions |
06/13/1991 | WO1991007946A1 Utilisation of extracts of algae for the preparation of pharmaceutical, cosmetic, food or agricultural compositions |
06/13/1991 | WO1991007945A1 Utilization of xanthines, optionally incorporated in liposomes in order to help the pigmentation of skin or hair |
06/13/1991 | WO1991007880A1 Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats |
06/13/1991 | WO1991007876A1 Active agent against retrovirus group viruses, compositions containing same and their use |
06/13/1991 | WO1991006293A3 Composition containing 2,3-butanedione monoxime and method for reversibly arresting muscle activity |
06/13/1991 | WO1991003248A3 Method for immune system activation |
06/13/1991 | WO1991000729A3 Bis-dioxopiperazines, and their use as protecting agents |
06/13/1991 | DE3941009A1 Eliminierung von aktivierten lymphozyten Elimination of activated lymphocytes |
06/13/1991 | CA2071497A1 2-substituted 4,5-diphenyl-imidazoles |
06/13/1991 | CA2069002A1 Gibberellins for the treatment of prostatitis and psoriasis |
06/13/1991 | CA2032004A1 Method for treatment of cocaine and heroin addiction comprising transdermal delivery of buprenorphine |
06/13/1991 | CA2031839A1 Piperidine derivatives, preparation thereof and pharmaceutical compositions containing the same |
06/12/1991 | WO1991009024A1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof |
06/12/1991 | WO1991009021A1 Imidazoles |
06/12/1991 | WO1991008679A1 Functional food |
06/12/1991 | EP0432099A2 Hydrogenated nitrogen containing heterocycles |
06/12/1991 | EP0432040A1 Heterocyclic derivatives of acylaminothiazole, their preparation and pharmaceutical compositions containing them |
06/12/1991 | EP0432039A2 Antipsychotic drug comprising an acylaminoacid |
06/12/1991 | EP0431991A1 1,8-Benzonaphthyridine derivatives, their preparation and compositions containing them |
06/12/1991 | EP0431972A2 Macrocyclic lactones having renin inhibiting properties |
06/12/1991 | EP0431945A2 Antiarrhythmic agents |
06/12/1991 | EP0431944A2 Benzofurazan derivatives having antiarrhythmic properties |
06/12/1991 | EP0431943A2 Nitrogen-containing spirocycles |
06/12/1991 | EP0431942A2 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative |
06/12/1991 | EP0431933A1 Formulated medicines for enhancing the efficacy of betalactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria |
06/12/1991 | EP0431884A2 Non-toxic wound cleansing compositions |
06/12/1991 | EP0431877A1 Cimetidine pharmaceutical compositions |
06/12/1991 | EP0431874A1 Novel compounds |
06/12/1991 | EP0431870A1 Amphotericin B derivatives |
06/12/1991 | EP0431856A2 Heterocyclic compounds |
06/12/1991 | EP0431828A1 Improvements relating to the administration of pharmaceutical agents |
06/12/1991 | EP0431799A2 Use of nucleoside derivatives as cytotoxic agents |
06/12/1991 | EP0431763A2 Therapeutic agents for lowering triglyceride and/or cholesterol levels and/or increasing HDL levels |
06/12/1991 | EP0431759A1 Process for the preparation of a ranitidine resin absorbate |
06/12/1991 | EP0431758A2 Use of adenosine agonists and antagonists in the treatment of alcohol abuse |
06/12/1991 | EP0431741A2 Substituted pyrimidineamino compounds |
06/12/1991 | EP0431736A1 Treatment of male hormone related diseases by cyclodextrins and their derivatives |
06/12/1991 | EP0431735A1 Improvement in diuresis by cyclodextrins and their derivatives |
06/12/1991 | EP0431719A1 Vaginal tissue moisturizing composition |
06/12/1991 | EP0431663A1 Stabilized solutions of psychotropic agents |
06/12/1991 | EP0431659A1 Pharmaceutical compositions of tebufelone |
06/12/1991 | EP0431580A2 Substituted cyclohexanols as central nervous system agents |
06/12/1991 | EP0431579A2 Substituted cyclohexenes as central nervous system agents |
06/12/1991 | EP0431536A1 A method of preparation of an extract from Gingko biloba leaves. |
06/12/1991 | EP0431535A1 Extract from Ginkgo biloba leaves, its method of preparation and pharmaceuticals containing the extract |
06/12/1991 | EP0431523A2 Modified nucleotide compounds |
06/12/1991 | EP0431520A2 Heterocyclic acyl aminodiol beta-amino acid derivatives |
06/12/1991 | EP0431519A1 System for transdermal albuterol administration |
06/12/1991 | EP0431480A2 Substituted 10-ring-lactones, process for their preparation and their use |
06/12/1991 | EP0431465A1 Dialysation- and rinsing-solution for intraperitoneal administration |
06/12/1991 | EP0431443A2 Use of tetrahydrocarbazolone derivatives for the manufacture of medicaments |
06/12/1991 | EP0431371A1 3-Aminopyrroles, process for this preparation and their use as medicaments |
06/12/1991 | EP0431323A1 Antitumor antibiotic BU-3983T |
06/12/1991 | EP0431321A1 Acat inhibitors |
06/12/1991 | EP0431277A1 Combination of a thromboxane A2 antagonist with a thrombolytic agent |
06/12/1991 | EP0431154A1 Wound healing agents containing 1-phenyl-2-aminoethanol derivatives and tincture of calendula |
06/12/1991 | EP0431008A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
06/12/1991 | EP0263138B1 Improvements in or relating to the treatment of sickle cell disease |
06/12/1991 | EP0242385B1 Process for preparing netilmicin |
06/12/1991 | CN1052117A Immunostimulating 6-aryl-5,6-dihydroimidazo (2.1-b) thiazole derivatives |
06/12/1991 | CN1052116A Process for preparing triazolyl thioamide derivatives |
06/12/1991 | CN1052112A Process for preparing naphthyl oxazolididone derivatives |
06/12/1991 | CN1052046A Pharmaceutical preparations |
06/12/1991 | CN1052045A Process for preparing paradenlal tissue regeneration promoter |
06/12/1991 | CN1012819B Process for preparing s-adenosyl-l-methionine and stable salts with polyanions |
06/12/1991 | CN1012815B Process for preparing gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes |
06/12/1991 | CA2071498A1 Imidazoles |
06/12/1991 | CA2046603A1 Quinazoline-3-alkanoic acid derivatives, their salts and their preparation processes |
06/12/1991 | CA2031916A1 Cycloheptimidazolone compounds as angiotension ii antagonists for control of hypertension |
06/12/1991 | CA2031898A1 Chemical compounds |
06/12/1991 | CA2031886A1 Therapeutic application of fluoro-quinolone derivetives |
06/12/1991 | CA2031650A1 Bu-4146t antibiotic |
06/12/1991 | CA2024968A1 Antidementia drug |
06/11/1991 | US5023364 Phenoxyalkylcarboxylic acid derivatives and process for their preparation |
06/11/1991 | US5023363 Antiinflammatory agent, antiallergens, skin disorders, vision defects |
06/11/1991 | US5023361 Reacting sulphonic acid or sulfate with decarboxylate ester |
06/11/1991 | US5023358 Vanadyl organo-mineral compound, method for obtaining such a compound, pharmaceutical composition containing this organo-mineral compound |
06/11/1991 | US5023357 Arylmethylazole preparation processes |
06/11/1991 | US5023341 Acetylene thiochroman |
06/11/1991 | US5023340 Glycosidase inhibitors |
06/11/1991 | US5023335 1,2-bis (aminomethyl) cyclobutane-platinum complexes |
06/11/1991 | US5023273 6-oxoprostaglandin E derivatives, process for their production and their pharmaceutical use |
06/11/1991 | US5023272 Use of 5-phenyl-2-furan esters and amides as antiepileptic agents |